Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Unraveling the Mystery of Prognostic and Predictive Factors in Epidermal Growth Factor Receptor Therapy

28 Feb 2006

Abstract excerpt

TO THEEDITOR: We write in response to the articles of Hirsch et al 1 and Takano et al 2 and the editorial by Johnson and Janne 3 concerning predictive epidermal growth factor receptor (EGFR) markers for sensitivity to tyrosine kinase inhibition in patients with non–small-cell lung cancer. These and other authors have concluded from their analyses of gene copy number and mutational status that the presence of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Genomics and Diagnostics
Share to Colorectal Cancer Treatments and Studies
Share to Lung Cancer Treatments and Mutations

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 16505443
DOI: 10.1200/jco.2005.04.4420

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 8 closest

Unraveling the Mystery of Prognostic and Predictive Factors in Epidermal Growth Factor Receptor TherapyPMID 16505443Read ↗

Prognostic significance associated with the number of compound mutations in epidermal growth factor receptor-mutated non-small cell lung cancer.Semantic proximity Read ↗

Prognostic and predictive value of epidermal growth factor receptor tyrosine kinase domain mutation status and gene copy number for adjuvant chemotherapy in non-small cell lung cancer.Semantic proximity Read ↗

Epidermal growth factor receptor revisited: prognostic marker or target for therapy?Semantic proximity Read ↗

The importance of molecular profiling in predicting response to epidermal growth factor receptor family inhibitors in non-small-cell lung cancer: focus on clinical trial results.Semantic proximity Read ↗

Predictive factors for epidermal growth factor receptor inhibitors--the bull's-eye hits the arrow.Semantic proximity Read ↗

Predictive Molecular Markers of Response to Epidermal Growth Factor Receptor(EGFR) Family-Targeted TherapiesSemantic proximity Read ↗

Personalized Cancer Medicine: Molecular Diagnostics, Predictive biomarkers, and Drug ResistanceSemantic proximity Read ↗

Usefulness of predictive tests for cancer treatment.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.